We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for plozasiran (Arrowhead Australia Pty Ltd)
Active ingredients
plozasiran
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
As an adjunct to diet to reduce triglyceride levels for adult patients with genetically confirmed or clinically diagnosed familial chylomicronemia syndrome (FCS) for whom standard triglyceride lowering therapies have been inadequate
Therapeutic area
Cardiovascular